Nighthawk Biosciences Inc

0.0098 (1.46%)


Draw Mode:

Volume 32,526
Bid Price
Ask Price
News -
Day High 0.68


52 Week Range


Day Low 0.66
Company Name Stock Ticker Symbol Market Type
Nighthawk Biosciences Inc NHWK AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.0098 1.46% 0.6798 16:20:23
Open Price Low Price High Price Close Price Prev Close
0.67 0.66 0.68 0.6798 0.67
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
241 32,526 $ 0.6693376 $ 21,771 - 0.65 - 3.42
Last Trade Time Type Quantity Stock Price Currency
16:32:31 20 $ 0.686 USD

Nighthawk Biosciences Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 17.71M 26.05M 24.71M $ 765.90k $ -128.98k -0.49 -137.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 9.90%

more financials information »

Nighthawk Biosciences News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No NHWK Message Board. Create One! See More Posts on NHWK Message Board See More Message Board Posts

Historical NHWK Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.72860.7367990.650.68210752,871-0.0488-6.7%
1 Month0.730.7997990.650.724529546,861-0.0502-6.88%
3 Months0.930.960.650.77462343,524-0.2502-26.9%
6 Months1.191.300.650.920731255,359-0.5102-42.87%
1 Year2.343.420.652.04123,241-1.66-70.95%
3 Years2.503.420.652.05120,159-1.82-72.81%
5 Years2.503.420.652.05120,159-1.82-72.81%

Nighthawk Biosciences Description

Heat Biologics, Inc. is registered with the U.S. Security and Exchange Commission and incorporated in the state of Delaware. Heat Biologics, Inc is primarely in the business of pharmaceutical preparations. For financial reporting, their fiscal year ends on December 31st. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Heat Biologics, Inc.. Heat Biologics Inc is a US-based immuno-oncology company. It is engaged in developing therapies that activate a patient's immune system against cancer utilizing an engineered form of gp96. The group's T cell-stimulating therapeutic vaccine platform technologies, Immune Pan-Antigen Cytotoxic Therapy (ImPACT) and Combination Pan-Antigen Cytotoxic Therapy (ComPACT), form the basis of its product candidates.